Association of cyclin D1 expression in lung cancer and the smoking habits of patients

Cancer Letters

Volumn 141, Issue 1-2, 1999, Pages 147-150

  Volm, M ^a   Koomagi R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cyclin D1; Immunohistochemistry; Non small cell lung carcinomas; Smoking

Indexed keywords

CYCLIN D1;

ADENOCARCINOMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING HABIT; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMOKING;

MARTES PENNANTI; NICOTIANA TABACUM;

EID: 0344417051     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00097-X     Document Type: Article

References (18)

1. Boyle P. Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October. Lung Cancer. 17:1997;1-60.
2. Jedrychowsky W., Becher H., Wahrendorf J., Basa-Cierpialek Z., Gomola K. Effect of tobacco smoking on various histological types of lung cancer. Cancer Res. Clin. Oncol. 118:1992;276-282.
3. Rodenhuis S., van de Wetering W.L., Mooi W.J., Evers S.G., van Zandwijk N., Bos J.L. Mutational activation of the K-ras oncogene. N. Engl. J. Med. 317:1987;929-935.
4. Volm M., Efferth T., Mattern J., Wodrich W. Overexpression of c-fos and c-erbB-1 encoded proteins in squamous cell carcinomas of the lung of smokers. Int. J. Oncol. 1:1992;69-71.
5. Wodrich W., Volm M. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis. 14:1993;1121-1124.
6. Keyomarsi K., Pardee A.B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA. 90:1993;1112-1116.
7. Schauer I.E., Siriwardana S., Langan T.A., Sclafani R.A. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc. Natl. Acad. Sci USA. 91:1994;7827-7831.
8. Davidson B.J., Lydiatt W.M., Abate M.P., Chantz S.P., Chaganti R.S. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma. Head Neck. 18:1996;512-521.
9. Cordon-Cardo C. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am. J. Pathol. 147:1995;545-560.
10. World Health Organization, Histological typing of lung tumors, Tumori, 6 (1981) 253-272.
11. Carr D.T., Mountain C.F. Staging lung cancer. Strauss M.J. Lung Cancer: Clinical Diagnosis and Treatment. 1977;151-161 Grune and Stratton, New York.
12. Volm M., Mattern J., Samsel B. Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein, and glutathione S-transferase-π in human lung tumors. Cancer. 71:1993;3181-3187.
13. Hunter T., Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
14. Bianchi A.B., Fisher S.M., Robles A.I., Rinchik E.M., Conti C.J. Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene. 8:1993;1127-1133.
15. Robles A.I., Conti C.J. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis. 16:1995;781-786.
16. Maelandsmo G.M., Florenes V.A., Hovig E., Oyjord T., Engebraaten O., Holm R., Borresen A.-L., Fodstad O. Involvement of the pRb/p16/cdk4/cyclinD1 pathway in the tumorigenesis of sporadic malignant melanomas. Br. J. Cancer. 73:1996;909-916.
17. Mittnacht S., Weinberg R.A. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell. 65:1991;381-393.
18. Chellappan S.P., Hiebert S., Mudry J.M., Horowitz J.M., Newins J.R. The E2F transcription factor is a cellular target for the Rb protein. Cell. 65:1991;1053-1062.